These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7068050)

  • 1. The influence of various combinations of plasminogen and streptokinase on fibrinolysis. II. A mechanistic study.
    Gaffney PJ; Joe F; Rose EA; Whitaker AN
    Haemostasis; 1982; 11(1):2-11. PubMed ID: 7068050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of various combinations of plasminogen and streptokinase on fibrinolysis.
    Gaffney PJ; Joe F; Rowe EA; Whitaker AN
    Haemostasis; 1981; 10(6):304-14. PubMed ID: 7327440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dissolution of human cross-linked plasma fibrin clots by the equimolar human plasmin-derived light (B) chain-streptokinase complex. The acceleration of clot lysis by pretreatment of fibrin clots with the light (B) chain.
    Summaria L; Boreisha IG; Arzadon L; Robbins KC
    Thromb Res; 1977 Sep; 11(3):377-89. PubMed ID: 144332
    [No Abstract]   [Full Text] [Related]  

  • 4. Biological effects of the administration of an equimolar streptokinase-plasminogen complex in man.
    Verstraete M; Vermylen J; Holleman W; Barlow GH
    Thromb Res; 1977 Aug; 11(2):227-36. PubMed ID: 905974
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma cross-linked fibrin degradation product (XLFbDP) assays in an in vivo model of fibrinolysis.
    Rowbotham BJ; Whitaker AN; Masci PP
    Blood Coagul Fibrinolysis; 1990 Dec; 1(6):653-61. PubMed ID: 2133245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The thrombolytic activity of streptokinase in the rabbit.
    English PD; Smith RA; Dupe RJ; Green J; Hibbs MJ
    Thromb Haemost; 1981 Aug; 46(2):535-7. PubMed ID: 7302893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of plasmin, microplasmin, and streptokinase-plasmin complex for the in vitro degradation of fibronectin and laminin- implications for vitreoretinal surgery.
    Hermel M; Dailey W; Hartzer MK
    Curr Eye Res; 2010 May; 35(5):419-24. PubMed ID: 20450255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for a sustained fibrinolytic response to anisoylated plasminogen streptokinase activator complex in vitro.
    Fears R
    Drugs; 1987; 33 Suppl 3():83-7. PubMed ID: 3315617
    [No Abstract]   [Full Text] [Related]  

  • 9. The activation of Glu- and Lys-plasminogens by streptokinase: effects of fibrin, fibrinogen and their degradation products.
    Takada A; Takada Y; Sugawara Y
    Thromb Res; 1985 Feb; 37(3):465-75. PubMed ID: 3992529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The evaluation of plasmin and streptokinase activator complexes in a new rabbit model of venous thrombosis.
    Dupe RJ; English PD; Smith RA; Green J
    Thromb Haemost; 1981 Aug; 46(2):528-34. PubMed ID: 6458112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced activator activity of the mixture of streptokinase and a modified form of plasminogen (Lys-plasminogen) in the presence of fibrin: role of conformational change of plasminogen.
    Takada A; Takada Y; Sugawara Y
    Haemostasis; 1988; 18(2):106-12. PubMed ID: 3410360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of the activation of Glu-plasminogen by streptokinase and urokinase in the presence of fibrinogen degradation products.
    Takada A; Takada Y
    Thromb Res; 1982 Feb; 25(3):229-35. PubMed ID: 7038978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of urinary fibrin/fibrinogen degradation products by radioimmunoassay.
    Ekberg M; Hedner U; Larsson I; Nilsson IM; Nosslin B
    Scand J Clin Lab Invest; 1976 Sep; 36(5):453-9. PubMed ID: 790536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrin clot lysis by thrombolytic agents is impaired in newborns due to a low plasminogen concentration.
    Andrew M; Brooker L; Leaker M; Paes B; Weitz J
    Thromb Haemost; 1992 Sep; 68(3):325-30. PubMed ID: 1440499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zymogen activation in the streptokinase-plasminogen complex. Ile1 is required for the formation of a functional active site.
    Wang S; Reed GL; Hedstrom L
    Eur J Biochem; 2000 Jul; 267(13):3994-4001. PubMed ID: 10866798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The formation of a fibrinogen-activator complex by the action of streptokinase.
    Chesterman CN; Cederholm-Williams SA; Allington MJ; Sharp AA
    Thromb Res; 1977 Mar; 10(3):421-30. PubMed ID: 854878
    [No Abstract]   [Full Text] [Related]  

  • 17. Proceedings: Fibrinolysis versus fibrinogenolysis: the specificity of human vascular activator (VA) as compared to urokinase (UK) and streptokinase (SK).
    Lipinski B; Gurewich V; Hyde E
    Thromb Diath Haemorrh; 1975 Sep; 34(1):351. PubMed ID: 1188799
    [No Abstract]   [Full Text] [Related]  

  • 18. Kinetic analyses of potentiation of plasminogen activation by streptokinase in the presence of fibrin or its degradation products.
    Takada Y; Takada A
    Haemostasis; 1987; 17(1-2):1-7. PubMed ID: 3596355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble high-molecular-weight E fragments in the plasmin-induced degradation products of cross-linked human fibrin.
    Gaffney PJ; Lane DA; Brasher M
    Clin Sci Mol Med; 1975 Aug; 49(2):149-56. PubMed ID: 125178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic properties of the activator complexes plasmin--staphylokinase and plasmin(ogen)--streptokinase in vitro.
    Sazonova IY; Aisina RB; Muhametova LI; Varfolomeyev SD
    Biochemistry (Mosc); 1999 Jan; 64(1):66-74. PubMed ID: 9986915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.